Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chauvin

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Medical and Pediatric Oncology|February 1, 1997
Screening for neuroblastoma in France: methodological aspects and preliminary observationsF Chauvin, P Mathieu, D Frappaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Gene Therapy|August 24, 1999
A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein EL Cioffi, F G Sturtz, S Wittmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor RegistryR Ladenstein, T Philip, C Lasset, et al.
Cell Biology and Toxicology|December 1, 1996
Advantages and limitations of the use of isolated kidney tubules in pharmacotoxicologyM F Chauvin, C Bolon, A Conjard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective seriesJ Y Blay, T Conroy, C Chevreau, et al.
BMC Cancer|January 7, 2023
Patient navigation for colorectal cancer screening in deprived areas: the COLONAV cluster randomized controlled trialA Bourmaud, Y Benoist, F Tinquaut, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 29, 1999
[Implantation of autologous chondrocytes for cartilagenous lesions in young patients. A study of 24 cases]J Bahuaud, R C Maitrot, R Bouvet, et al.
International Journal of Cancer|May 14, 1998
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)H Mignotte, C Lasset, V Bonadona, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)]C Marchal, M Lapeyre, V Beckendorf, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Medical and Pediatric Oncology|February 1, 1997
Screening for neuroblastoma in France: methodological aspects and preliminary observationsF Chauvin, P Mathieu, D Frappaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Gene Therapy|August 24, 1999
A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein EL Cioffi, F G Sturtz, S Wittmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor RegistryR Ladenstein, T Philip, C Lasset, et al.
Cell Biology and Toxicology|December 1, 1996
Advantages and limitations of the use of isolated kidney tubules in pharmacotoxicologyM F Chauvin, C Bolon, A Conjard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective seriesJ Y Blay, T Conroy, C Chevreau, et al.
BMC Cancer|January 7, 2023
Patient navigation for colorectal cancer screening in deprived areas: the COLONAV cluster randomized controlled trialA Bourmaud, Y Benoist, F Tinquaut, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 29, 1999
[Implantation of autologous chondrocytes for cartilagenous lesions in young patients. A study of 24 cases]J Bahuaud, R C Maitrot, R Bouvet, et al.
International Journal of Cancer|May 14, 1998
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)H Mignotte, C Lasset, V Bonadona, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)]C Marchal, M Lapeyre, V Beckendorf, et al.
Pageof 15